How should a levonorgestrel‑releasing intrauterine system (Mirena) be inserted in a woman with a bicornuate uterus?

Mirena Insertion in Bicornuate Uterus

Mirena insertion in a bicornuate uterus is generally contraindicated (Category 4) because the distorted uterine cavity is incompatible with proper IUD placement, which significantly increases risks of malposition, expulsion, perforation, and contraceptive failure. 1

Key Guideline Classification

The U.S. Medical Eligibility Criteria for Contraceptive Use explicitly categorizes anatomical abnormalities that distort the uterine cavity as Category 4 for both LNG-IUD and Cu-IUD initiation and continuation 1. This means:

• Category 4 = Unacceptable health risk
• The anatomic abnormality precludes proper IUD placement
• A bicornuate uterus creates two separate uterine cavities with incomplete fundal fusion, fundamentally incompatible with standard IUD design

Clinical Reasoning

A bicornuate uterus results from incomplete fusion of the Müllerian ducts, creating two distinct uterine horns that share a common lower segment 2. Standard Mirena devices are designed for a single, normally-shaped uterine cavity. Attempting insertion in this malformation leads to:

• Improper positioning: The IUD cannot sit correctly in either horn
• Increased expulsion rates: Already elevated with other structural abnormalities like fibroids (11% vs 0-3%) 1
• Higher perforation risk: Abnormal anatomy increases procedural complications
• Contraceptive failure: Malpositioned devices lose efficacy
• Device fragmentation: Case reports document IUD fragmentation requiring hysteroscopic removal in bicornuate uteri 3

Alternative Approach (Expert Case Reports Only)

Only in highly specialized circumstances with expert complex family planning consultation, placement of two separate Mirena devices—one in each uterine horn—has been reported 4. This approach:

• Requires hysteroscopic guidance for placement
• Necessitates imaging confirmation of proper positioning in both horns
• Should only be performed by subspecialists experienced in complex IUD placement
• Has extremely limited evidence (single case reports)
• Carries unknown long-term safety profile

This dual-device approach was documented in a breast cancer patient requiring endometrial protection while on tamoxifen 4, representing an exceptional clinical scenario where benefits potentially outweighed risks.

Recommended Management Algorithm

For contraception needs:

1. Do not attempt standard Mirena insertion
2. Offer alternative highly effective contraception:
   • Etonogestrel implant (Nexplanon) - Category 1, no anatomic contraindication 5
   • DMPA injection - equally effective, no anatomic limitation
   • Combined hormonal contraceptives if no contraindications

For heavy menstrual bleeding management:

1. Consider medical management (tranexamic acid, NSAIDs, hormonal therapy)
2. Refer to complex family planning or reproductive endocrinology for specialized evaluation
3. Surgical options (endometrial ablation, metroplasty) may be appropriate depending on fertility desires

If dual-horn IUD placement is considered:

1. Refer immediately to complex family planning subspecialist
2. Requires pre-procedural 3D ultrasound or MRI to map uterine anatomy 6
3. Hysteroscopic placement mandatory
4. Post-procedure imaging to confirm bilateral proper positioning
5. Enhanced surveillance for complications

Critical Pitfalls to Avoid

• Never attempt blind insertion in known bicornuate uterus—this guarantees malposition
• Do not rely on ultrasound guidance alone for standard single-device placement—the anatomy is fundamentally incompatible
• Recognize that "other abnormalities not distorting the cavity" (Category 2) 1 does NOT apply to bicornuate uterus, which definitively distorts the cavity
• Avoid assuming successful insertion based on string visualization—malposition is highly likely even if strings are visible

Evidence Quality Note

The guideline evidence is strong and consistent across multiple CDC publications 1. The Category 4 classification reflects expert consensus that anatomic distortion creates unacceptable risk. Case reports of dual-device placement 4 represent exceptional circumstances requiring subspecialty expertise and should not guide general practice.